CRISPR

CRISPR1-inha

ID

ZDB-CRISPR-210921-2

Name

CRISPR1-inha

Previous Names

None

Target

inha (1)

Sequence

5' - GGCTTTGTTTTCTCCTCCAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

The PAM site was "CGG" at the 5' end.

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
umo19	inha

Expression

Gene expression in Wild Types + CRISPR1-inha

No data available

Phenotype

Phenotype resulting from CRISPR1-inha

No data available

Phenotype of all Fish created by or utilizing CRISPR1-inha

Phenotype	Fish	Conditions	Figures
ovarian follicle oocyte morphology, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 7 from Lu et al., 2020
female organism hypophysis fshb expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 2 from Lu et al., 2020
ovarian follicle stage II increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 6 from Lu et al., 2020
ovary inhbaa expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 4 from Lu et al., 2020
ovarian follicle stage III increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 6 from Lu et al., 2020
testis neoplastic, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 9 from Lu et al., 2020
ovary inha expression decreased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 4 from Lu et al., 2020
ovulation disrupted, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 8 from Lu et al., 2020
ovarian follicle granulosa cell hypertrophic, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 7 from Lu et al., 2020
ovarian follicle stage I decreased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 6 from Lu et al., 2020
testis inha expression decreased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 4 from Lu et al., 2020
female organism female sterile, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 8 from Lu et al., 2020
testis inhbaa expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 4 from Lu et al., 2020
testis amh expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 3 from Lu et al., 2020
testis dmrt1 expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 3 from Lu et al., 2020
male organism hypophysis fshb expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 2 from Lu et al., 2020
oocyte maturation disrupted, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 8 from Lu et al., 2020
developmental process involved in reproduction premature, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 6 from Lu et al., 2020
ovarian follicle granulosa cell layer hypertrophic, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 8 from Lu et al., 2020
testis fshr expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 3 from Lu et al., 2020
female organism hypophysis fsta expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 2 from Lu et al., 2020
female organism hypophysis lhb expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 2 from Lu et al., 2020
testis gsdf expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 3 from Lu et al., 2020
ovary cyp19a1a expression increased amount, abnormal	inha^umo19/umo19 (AB)	standard conditions	Fig. 3 from Lu et al., 2020
hypophysis female organism fshb expression increased amount, abnormal	amh^umo17/+; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
hypophysis female organism fshb expression decreased amount, abnormal	amh^umo17/umo17; inha^umo19/+	standard conditions	Fig. 6 from Zhang et al., 2020
hypophysis male organism fshb expression decreased amount, abnormal	amh^umo17/umo17; inha^umo19/+	standard conditions	Fig. 6 from Zhang et al., 2020
ovarian follicle stage II increased amount, abnormal	amh^umo17/umo17; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
spermatogonium increased amount, abnormal	amh^umo17/umo17; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
testis increased size, abnormal	amh^umo17/umo17; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
ovarian follicle stage I increased amount, abnormal	amh^umo17/umo17; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
testis hypertrophic, abnormal	amh^umo17/umo17; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
ovary increased size, abnormal	amh^umo17/umo17; inha^umo19/umo19	standard conditions	Fig. 6 from Zhang et al., 2020
ovary fibrotic, abnormal	egfra^umo21/umo21; inha^umo19/umo19 (AB)	standard conditions	FIGURE 11 from Song et al., 2022
ovarian follicle development arrested, abnormal	egfra^umo21/umo21; inha^umo19/umo19 (AB)	standard conditions	FIGURE 11 from Song et al., 2022
ovarian follicle stage I increased amount, abnormal	egfra^umo21/umo21; inha^umo19/umo19 (AB)	standard conditions	FIGURE 11 from Song et al., 2022

Citations